CSIMarket Company Name, Ticker, Competitors, else..
 

Haemonetics Corporation  (NYSE: HAE)

Haemonetics's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

HAE Sales vs. its Competitors Q1 2026


Comparing the current results to its competitors, Haemonetics reported Revenue increase in the 1 quarter 2026 by 5.65 % year on year.
The sales growth was above Haemonetics's competitors' average revenue growth of 4.59 %, achieved in the same quarter.

• List of HAE Competitors

With a net margin of 9.73 % Haemonetics reported lower profitability than its competitors.

• More on HAE Profitability Comparisons



Revenue Growth Comparisons




Net Income Comparison

Haemonetics Corporation Net Income in the 1 quarter 2026 fell year on year by -3%, slower than its competitors' income growth of 2.54 %

<<  HAE Stock Performance Comparisons


Haemonetics's Comment on Competition and Industry Peers


The company utilizes patents, unpatented know-how, trade secrets, and the technical expertise of its personnel to sustain its competitive position. It is involved in intellectual property litigation to enforce its patent rights and safeguard its trade secrets. However, patents issued or licensed to the company may be subject to challenges or invalidation by competitors.



  

Overall company Market Share Q1 2026
With revenue growth of 5.65 % within Overall company, Haemonetics Corporation achieved improvement in market share, within Overall company to approximately 1.44 %.
<<  More on HAE Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Haemonetics Corporation




Cerus Corporation
Share Performance



-1.18%
Over The Past 5 Days
Cerus Corporation
Profile

Cerus Corporation's business model revolves around developing and commercializing innovative technologies and products for the enhancement of blood safety.

More about Cerus Corporation's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 503.418 mill. $ 221.224 mill. $ -6.834 mill.


Precision Optics Corporation Inc
Share Performance



-0.23%
Over The Past 5 Days
Precision Optics Corporation Inc
Profile

Precision Optics Corporation Inc is a company that specializes in designing and manufacturing advanced optical systems for medical and defense industries. They focus on delivering high-precision solutions to meet the complex optical needs of their customers.

More about Precision Optics Corporation Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 33.827 mill. $ 28.939 mill. $ -4.929 mill.


Livanova Plc
Share Performance



-1.40%
Over The Past 5 Days
Livanova Plc
Profile

Livanova Plc is a global medical technology company that focuses on developing and delivering innovative solutions for patients with cardiovascular diseases and neuropsychiatric disorders. Through their diverse portfolio, they offer products and therapies that encompass surgical heart valves, cardiac rhythm management, and neuromodulation. Livanova adopts a patient-centric approach, collaborating with healthcare professionals to improve patient outcomes and enhance quality of life.

More about Livanova Plc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 4,477.404 mill. $ 1,470.112 mill. $ 188.553 mill.


Koru Medical Systems Inc
Share Performance



-44.12%
This Year
Koru Medical Systems Inc
Profile

Koru Medical Systems Inc has a business model centered around providing medical solutions or services.

More about Koru Medical Systems Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 155.212 mill. $ 45.108 mill. $ -1.819 mill.


Icu Medical Inc
Share Performance



-13.81%
30 Days
Icu Medical Inc
Profile

ICU Medical Inc's business model focuses on the development, manufacture, and sale of innovative medical devices and solutions for critical care settings.

More about Icu Medical Inc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 3,952.695 mill. $ 2,159.998 mill. $ 30.089 mill.

7 more competitors available

Sign in to see all competitors

Sign In Create Free Account

Sources: Haemonetics Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Haemonetics Corporation versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.